Next Treatments
Back to Eczema

QY201

TypePill StagePhase 3 Latest updateDec 19, 2025Phase 2 study completed

History

Earliest recorded event: Sep 2, 2022. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Dec 19, 2025Phase 2 trial completedPhase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT07712536
  • Jun 4, 2025Phase 2 trial startedPhase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT07712536
  • Mar 12, 2025Phase 3 trial startedA Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis. ClinicalTrials.gov NCT07180511
  • Sep 2, 2022Phase 1/2 trial posted · Status not confirmed by the sponsorA Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT05525715

Sources

Trials